During the past decade, Groupe Hospitalier Sud Hopital Haut Leveque USN conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Sud Hopital Haut Leveque USN" are "Crohn Disease" (3 trials), "Anemia" (1 trials), "Crohn's Disease" (1 trials), "Hepatitis C" (1 trials) and "Myelofibrosis" (1 trials). Many other conditions were trialed in "Groupe Hospitalier Sud Hopital Haut Leveque USN" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier Sud Hopital Haut Leveque USN" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Etrolizumab" (2 trials), "GED-0301" (2 trials), "ACE-536" (1 trials) and "Etrozulimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier Sud Hopital Haut Leveque USN" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Groupe Hospitalier Sud Hopital Haut Leveque USN". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Groupe Hospitalier Sud Hopital Haut Leveque USN, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier Sud Hopital Haut Leveque USN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".